$CELC

$65.80 +$0.55 (0.84%) Close

$CELC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$CELC Management Team

Dr. Charlotte Moser

Chief Medical Officer

Age -

Compensation -

Sex Female

Ms. Vicky Hahne

Chief Financial Officer

Age 58

Compensation $1.351M USD

Sex Female

Mr. Brian Sullivan

Chairman of the Board

Chief Executive Officer

Co-Founder

Age 63

Compensation $6.587M USD

Sex Male

Dr. Lance Laing

Co-Founder

Chief Science Officer

Vice President

Secretary

Director

Age 63

Compensation $1.703M USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Charlotte Moser Chief Medical Officer	-	-	Female
Ms. Vicky Hahne Chief Financial Officer	58	$1.351M USD	Female
Mr. Brian Sullivan Chairman of the Board Chief Executive Officer Co-Founder	63	$6.587M USD	Male
Dr. Lance Laing Co-Founder Chief Science Officer Vice President Secretary Director	63	$1.703M USD	Male

Board of Directors

From the proxy statement filed Apr 2, 2026

Directors

serving now

Independent

6 of 6

stated in the proxy; 2 not stated

Average tenure

8.4 years

from year joined

CEO also chairs the board

Yes

Brian F. Sullivan

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Richard E. Buller	76	2019 7 years	Independent	Compensation Committee Nominating and Corporate Governance Committee	None stated	$140,000
David F. Dalvey	67	2014 12 years	Independent	Audit Committee Compensation Committee	None stated	$140,000
Leo T. Furcht	79	2019 7 years	Independent	Compensation Committee Nominating and Corporate Governance Committee	None stated	$140,000
Lance G. Laing Executive officer	64	2012 14 years	Not stated	None stated	None stated	Not stated
Polly A. Murphy	61	2022 4 years	Independent	Audit Committee Compensation Committee	Atea Pharmaceuticals, Inc.	$140,000
Richard J. Nigon	78	2017 9 years	Independent	Audit Committee Nominating and Corporate Governance Committee	Northern Technologies International Corporation	$140,000
Charles R. Romp	58	2026 0 years	Independent	None stated	None stated	Not stated
Brian F. Sullivan Board chair, CEO	64	2012 14 years	Not stated	None stated	None stated	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 2, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments